zepbound lilly news - Search News

GLP-1 Zepbound Is Approved

Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea

Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.

BioSpace · 9h

Lilly’s Zepbound Snags First Ever Sleep Apnea Drug Approval

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in combination with diet and exercise.

verywellhealth · 5h

Zepbound Gets FDA Approval to Treat Sleep Apnea

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA announced today.

Zepbound helps shed more weight than Wegovy, Eli Lilly study says

A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.

NBC Connecticut3d

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder. The weekly injection is now ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

GLP-1 Zepbound Is Approved

Trending now

Related topics